REVELATION BIOSCIENCES, INC.

Revelation Biosciences, Inc., trading under ticker PAIC, is the post-combination entity formed when Panacea Acquisition Corp. II, a healthcare-focused SPAC sponsored by EcoR1 Capital, completed its business combination with Revelation Biosciences, a San Diego-based immunology company focused on mucosal immunity and adjuvant-based therapeutic platforms. Panacea Acquisition Corp. II completed its IPO in 2021 and operates within the life sciences and biotechnology sector. The company filed its 10-K annual report on April 15, 2022, under accession number 0001213900-22-020179, reflecting its first full reporting cycle as a public combined entity. Sign up at SpacDesk for full filing history, sponsor data, and deal analytics on PAIC and hundreds of other SPACs.